Ye Yang

7.7k total citations · 2 hit papers
231 papers, 4.9k citations indexed

About

Ye Yang is a scholar working on Molecular Biology, Hematology and Oncology. According to data from OpenAlex, Ye Yang has authored 231 papers receiving a total of 4.9k indexed citations (citations by other indexed papers that have themselves been cited), including 138 papers in Molecular Biology, 48 papers in Hematology and 43 papers in Oncology. Recurrent topics in Ye Yang's work include Multiple Myeloma Research and Treatments (42 papers), Ubiquitin and proteasome pathways (16 papers) and Natural product bioactivities and synthesis (15 papers). Ye Yang is often cited by papers focused on Multiple Myeloma Research and Treatments (42 papers), Ubiquitin and proteasome pathways (16 papers) and Natural product bioactivities and synthesis (15 papers). Ye Yang collaborates with scholars based in China, United States and Hong Kong. Ye Yang's co-authors include Chunyan Gu, Jinjun Qian, Mengjie Guo, Fenghuang Zhan, Yuanjiao Zhang, Ge Lin, Guido Tricot, Xiaozhu Tang, Peter P. Fu and Hongwei Xu and has published in prestigious journals such as Nucleic Acids Research, Journal of Biological Chemistry and Angewandte Chemie International Edition.

In The Last Decade

Ye Yang

219 papers receiving 4.8k citations

Hit Papers

Alternative splicing and ... 2021 2026 2022 2024 2021 2021 50 100 150 200 250

Author Peers

Peers are selected by citation overlap in the author's most active subfields. citations · hero ref

Author Last Decade Papers Cites
Ye Yang 3.1k 1.1k 742 678 382 231 4.9k
Xiang Xue 1.8k 0.6× 1.1k 1.0× 483 0.7× 367 0.5× 371 1.0× 111 4.1k
Hui Zhao 1.6k 0.5× 558 0.5× 330 0.4× 560 0.8× 219 0.6× 160 4.0k
Ming Zhao 3.1k 1.0× 567 0.5× 1.4k 1.9× 401 0.6× 289 0.8× 133 5.3k
Hongmei Li 2.6k 0.8× 937 0.9× 841 1.1× 293 0.4× 125 0.3× 165 4.7k
Xinguang Liu 2.1k 0.7× 785 0.7× 412 0.6× 829 1.2× 218 0.6× 255 4.9k
Melchiorre Cervello 3.4k 1.1× 1.1k 1.0× 1.3k 1.7× 201 0.3× 170 0.4× 137 6.0k
You Mie Lee 3.4k 1.1× 1.5k 1.3× 777 1.0× 143 0.2× 183 0.5× 119 5.0k
Ireneusz Majsterek 2.3k 0.7× 619 0.6× 591 0.8× 405 0.6× 69 0.2× 238 5.2k
Ismael Samudio 3.9k 1.2× 1.3k 1.2× 1.5k 2.0× 1.0k 1.5× 135 0.4× 95 6.8k

Countries citing papers authored by Ye Yang

Since Specialization
Citations

This map shows the geographic impact of Ye Yang's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Ye Yang with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Ye Yang more than expected).

Fields of papers citing papers by Ye Yang

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Ye Yang. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Ye Yang. The network helps show where Ye Yang may publish in the future.

Co-authorship network of co-authors of Ye Yang

This figure shows the co-authorship network connecting the top 25 collaborators of Ye Yang. A scholar is included among the top collaborators of Ye Yang based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Ye Yang. Ye Yang is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Wang, Ling, Jie Min, Jinjun Qian, et al.. (2025). SAE1 promotes tumor cell malignancy via SUMOylation and liquid–liquid phase separation facilitated nuclear export of p27. Acta Pharmaceutica Sinica B. 15(4). 1991–2007. 1 indexed citations
2.
Yan, Bowen, Chenhuan Lai, Ye Yang, et al.. (2025). The state-of-the-art preparation, purification and biological activities of mannan oligosaccharides. Industrial Crops and Products. 225. 120594–120594. 3 indexed citations
3.
Chiang, Nai‐Jung, Chung‐Ping Hsu, Jin‐Shing Chen, et al.. (2024). MO50-3 TCOG T3221 study: the registry of genetic alterations of Taiwan biliary tract cancer. Annals of Oncology. 35. S1355–S1355. 1 indexed citations
4.
Li, Feng, et al.. (2024). 3,3'-Diindolylmethane inhibits the proliferation of esophageal squamous cell carcinoma cells via downregulation of STIM1. Oncology Letters. 28(2). 339–339. 2 indexed citations
5.
Tang, Xiaozhu, et al.. (2024). Examining the evidence for mutual modulation between m6A modification and circular RNAs: current knowledge and future prospects. Journal of Experimental & Clinical Cancer Research. 43(1). 216–216. 3 indexed citations
6.
Tang, Chunping, et al.. (2024). Germacrane-type sesquiterpenes from Artemisia atrovirens and their anti-inflammatory activity. Fitoterapia. 179. 106241–106241. 1 indexed citations
7.
Wang, Zixuan, Jingjing Wang, Mengyuan Zhang, et al.. (2024). Unraveling the Promise of RET Inhibitors in Precision Cancer Therapy by Targeting RET Mutations. Journal of Medicinal Chemistry. 67(6). 4346–4375. 8 indexed citations
8.
Huang, Huizhen, Zhiheng Li, Yue Xia, et al.. (2023). Association between radiomics features of DCE-MRI and CD8+ and CD4+ TILs in advanced gastric cancer. Pathology & Oncology Research. 29. 1611001–1611001. 4 indexed citations
9.
Zhou, Jie, Ye Yang, & Shiwei Cheng. (2023). A Model to Personalized Text Summarization Generation Based on Eye Tracking. Journal of Computer-Aided Design & Computer Graphics. 35(10). 1620–1628.
10.
Crooks, Daniel R., Christopher J. Ricketts, Cathy D. Vocke, et al.. (2023). Cryptic splice mutation in the fumarate hydratase gene in patients with clinical manifestations of Hereditary Leiomyomatosis and Renal Cell Cancer. Human Molecular Genetics. 32(22). 3135–3145. 1 indexed citations
11.
Li, Xiaolu, et al.. (2023). Screening biomarkers for spinal cord injury using weighted gene co-expression network analysis and machine learning. Neural Regeneration Research. 19(12). 2723–2734. 11 indexed citations
12.
Wei, Rongfang, Yan Zhu, Yuanjiao Zhang, et al.. (2022). AIMP1 promotes multiple myeloma malignancy through interacting with ANP32A to mediate histone H3 acetylation. Cancer Communications. 42(11). 1185–1206. 12 indexed citations
13.
Qian, Jinjun, Wei Wu, Yanxin Zhang, et al.. (2021). Suppression of steroid 5α-reductase type I promotes cellular apoptosis and autophagy via PI3K/Akt/mTOR pathway in multiple myeloma. Cell Death and Disease. 12(2). 206–206. 18 indexed citations
14.
Tang, Lili, Chang Chen, Baomei Xia, et al.. (2020). Effect of Wenshen-Yanggan Decoction on Movement Disorder and Substantia Nigra Dopaminergic Neurons in Mice with Chronic Parkinson’s Disease. Evidence-based Complementary and Alternative Medicine. 2020(1). 9838295–9838295. 5 indexed citations
15.
Bei, Yuncheng, Nan Cheng, Ting Chen, et al.. (2020). CDK5 Inhibition Abrogates TNBC Stem‐Cell Property and Enhances Anti‐PD‐1 Therapy. Advanced Science. 7(22). 2001417–2001417. 38 indexed citations
16.
Chen, Chang, Baomei Xia, Wei Wu, et al.. (2019). Neuroprotective Effect of Echinacoside in Subacute Mouse Model of Parkinson’s Disease. BioMed Research International. 2019. 1–8. 40 indexed citations
17.
Sun, Dongdong, Feng Zhang, Jie Qian, et al.. (2018). 4′-hydroxywogonin inhibits colorectal cancer angiogenesis by disrupting PI3K/AKT signaling. Chemico-Biological Interactions. 296. 26–33. 21 indexed citations
18.
Yang, Ye, Yushan Tian, Su‐Xia Li, et al.. (2017). Extract of Sheng-Mai-San Ameliorates Myocardial Ischemia-Induced Heart Failure by Modulating Ca2+-Calcineurin-Mediated Drp1 Signaling Pathways. International Journal of Molecular Sciences. 18(9). 1825–1825. 35 indexed citations
19.
Gu, Zhimin, He Wang, Jiliang Xia, et al.. (2015). Decreased Ferroportin Promotes Myeloma Cell Growth and Osteoclast Differentiation. Cancer Research. 75(11). 2211–2221. 87 indexed citations
20.
Huang, Junwei, Yi Zhou, Gregory S. Thomas, et al.. (2015). NEDD8 Inhibition Overcomes CKS1B-Induced Drug Resistance by Upregulation of p21 in Multiple Myeloma. Clinical Cancer Research. 21(24). 5532–5542. 37 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026